SBC Scorecard | SBC Medical Group Holdings Incorporated

SBC Medical Group Holdings Incorporated (SBC) Scorecard

2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

4/25 0.8 / 5 stars All 25 Win/Lose results and 95 gray no-data contests shown below

Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.

Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q20/3	LoseSBC / S&P -26.32% / 15.20%	LoseSBC / S&P -6.92% / 15.00%	LoseSBC / S&P 46.87% / 50.40%
2026-Q11/3	WinSBC / S&P -3.02% / -4.33%	LoseSBC / S&P -14.45% / 11.30%	LoseSBC / S&P -22.00% / 27.70%
2025-Q40/3	LoseSBC / S&P -0.69% / 2.65%	LoseSBC / S&P -15.48% / 9.00%	LoseSBC / S&P -0.00% / 13.40%
2025-Q30/3	LoseSBC / S&P -6.47% / 8.12%	LoseSBC / S&P -20.10% / 4.61%	LoseSBC / S&P -29.31% / 13.45%
2025-Q21/3	WinSBC / S&P 45.45% / 10.94%	LoseSBC / S&P -13.49% / 4.83%	LoseSBC / S&P -50.00% / 10.63%
2025-Q10/1	LoseSBC / S&P -42.63% / -4.27%	No dataSBC / S&P / 4.98%	No dataSBC / S&P / 10.57%
2024-Q40/1	LoseSBC / S&P -30.24% / 2.41%	No dataSBC / S&P / 5.25%	No dataSBC / S&P / 6.15%
2024-Q30/1	LoseSBC / S&P -39.02% / 5.89%	No dataSBC / S&P / 5.89%	No dataSBC / S&P / 6.11%
2024-Q20/1	LoseSBC / S&P 2.91% / 4.28%	No dataSBC / S&P / 5.38%	No dataSBC / S&P / 5.12%
2024-Q11/1	WinSBC / S&P 17.92% / 10.56%	No dataSBC / S&P / 5.71%	No dataSBC / S&P / 5.59%
2023-Q40/1	LoseSBC / S&P 0.89% / 11.69%	No dataSBC / S&P / 6.81%	No dataSBC / S&P / 7.78%
2023-Q31/1	WinSBC / S&P 3.74% / -3.27%	No dataSBC / S&P / 7.52%	No dataSBC / S&P / -5.03%
2023-Q20/1	LoseSBC / S&P -1.44% / 8.74%	No dataSBC / S&P / 9.50%	No dataSBC / S&P / -8.57%
2023-Q10/1	LoseSBC / S&P 2.35% / 7.50%	No dataSBC / S&P / 10.77%	No dataSBC / S&P / -15.69%
2022-Q40/1	LoseSBC / S&P 1.80% / 7.56%	No dataSBC / S&P / 11.88%	No dataSBC / S&P / -17.99%
2022-Q30/0	No dataSBC / S&P / -4.88%	No dataSBC / S&P / 13.47%	No dataSBC / S&P / -1.41%
2022-Q20/0	No dataSBC / S&P / -16.10%	No dataSBC / S&P / 13.71%	No dataSBC / S&P / 11.04%
2022-Q10/0	No dataSBC / S&P / -4.60%	No dataSBC / S&P / 15.97%	No dataSBC / S&P / 42.23%
2021-Q40/0	No dataSBC / S&P / 11.03%	No dataSBC / S&P / 15.00%	No dataSBC / S&P / 96.40%
2021-Q30/0	No dataSBC / S&P / 0.58%	No dataSBC / S&P / 10.77%	No dataSBC / S&P / 69.42%
2021-Q20/0	No dataSBC / S&P / 8.55%	No dataSBC / S&P / 6.58%	No dataSBC / S&P / 51.81%
2021-Q10/0	No dataSBC / S&P / 6.17%	No dataSBC / S&P / -1.06%	No dataSBC / S&P / 7.39%
2020-Q40/0	No dataSBC / S&P / 12.15%	No dataSBC / S&P / -3.72%	No dataSBC / S&P / -33.42%
2020-Q30/0	No dataSBC / S&P / 8.93%	No dataSBC / S&P / -2.04%	No dataSBC / S&P / -27.10%
2020-Q20/0	No dataSBC / S&P / 20.54%	No dataSBC / S&P / -0.46%	No dataSBC / S&P / -27.11%
2020-Q10/0	No dataSBC / S&P / -19.60%	No dataSBC / S&P / 3.47%	No dataSBC / S&P / -14.75%
2019-Q40/0	No dataSBC / S&P / 9.07%	No dataSBC / S&P / 5.36%	No dataSBC / S&P / 2.99%
2019-Q30/0	No dataSBC / S&P / 1.70%	No dataSBC / S&P / 5.02%	No dataSBC / S&P / 0.21%
2019-Q20/0	No dataSBC / S&P / 4.30%	No dataSBC / S&P / 6.64%	No dataSBC / S&P / 8.65%
2019-Q10/0	No dataSBC / S&P / 13.65%	No dataSBC / S&P / 8.12%	No dataSBC / S&P / 14.29%
2018-Q40/0	No dataSBC / S&P / -13.52%	No dataSBC / S&P / 9.05%	No dataSBC / S&P / 18.23%
2018-Q30/0	No dataSBC / S&P / 7.71%	No dataSBC / S&P / 10.21%	No dataSBC / S&P / 19.06%
2018-Q20/0	No dataSBC / S&P / 3.43%	No dataSBC / S&P / 9.03%	No dataSBC / S&P / 14.46%
2018-Q10/0	No dataSBC / S&P / -0.76%	No dataSBC / S&P / 7.68%	No dataSBC / S&P / 12.46%
2017-Q40/0	No dataSBC / S&P / 6.64%	No dataSBC / S&P / 7.03%	No dataSBC / S&P / 13.82%
2017-Q30/0	No dataSBC / S&P / 4.48%	No dataSBC / S&P / 5.68%	No dataSBC / S&P / 17.57%
2017-Q20/0	No dataSBC / S&P / 3.09%	No dataSBC / S&P / 4.83%	No dataSBC / S&P / 17.74%
2017-Q10/0	No dataSBC / S&P / 6.07%	No dataSBC / S&P / 3.67%	No dataSBC / S&P / 13.32%
2016-Q40/0	No dataSBC / S&P / 3.82%	No dataSBC / S&P / 2.09%	No dataSBC / S&P / 7.05%
2016-Q30/0	No dataSBC / S&P / 3.85%	No dataSBC / S&P / 0.20%	No dataSBC / S&P / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	SBC total return	S&P 500 Total Return Index
Total return	0.74%	20.78%
Annualized return	0.74%	20.78%

5Y · 2022-09-26 to 2026-08-27

Metric	SBC total return	S&P 500 Total Return Index
Total return	-58.73%	83.14%
Annualized return	-16.22%	12.86%

10Y · 2022-09-26 to 2026-08-27

Metric	SBC total return	S&P 500 Total Return Index
Total return	-58.73%	319.30%
Annualized return	-8.47%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Airsculpt Technologies, Inc. (AIRS)	United States	$0.146B	-27.36
LifeMD, Inc. (LFMD)	United States	$0.141B	982.53
Teladoc Health, Inc. (TDOC)	United States	$1.114B	-8.68